home / stock / lobe:cc / lobe:cc quote
Last: | $0.02 |
---|---|
Change Percent: | 0.0% |
Open: | $0.02 |
Close: | $0.02 |
High: | $0.02 |
Low: | $0.02 |
Volume: | 350,000 |
Last Trade Date Time: | 05/06/2022 04:57:10 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 350,000 | 05-06-2022 |
$0.025 | $0.025 | $0.025 | $0.025 | $0.02 | 205,525 | 05-04-2022 |
$0.025 | $0.02 | $0.025 | $0.025 | $0.02 | 750,700 | 04-29-2022 |
$0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 25,180 | 04-27-2022 |
$0.02 | $0.025 | $0.02 | $0.025 | $0.02 | 134,500 | 04-25-2022 |
$0.025 | $0.025 | $0.025 | $0.025 | $0.02 | 684,397 | 04-22-2022 |
$0.015 | $0.025 | $0.015 | $0.025 | $0.015 | 1,717,740 | 04-20-2022 |
$0.025 | $0.02 | $0.025 | $0.025 | $0.02 | 655,102 | 04-19-2022 |
$0.025 | $0.025 | $0.025 | $0.025 | $0.025 | 3,079 | 04-18-2022 |
$0.02 | $0.025 | $0.02 | $0.025 | $0.02 | 108,550 | 04-12-2022 |
$0.02 | $0.025 | $0.02 | $0.025 | $0.02 | 177,650 | 04-07-2022 |
$0.025 | $0.025 | $0.025 | $0.025 | $0.02 | 413,498 | 04-06-2022 |
$0.025 | $0.025 | $0.025 | $0.025 | $0.025 | 4,773 | 04-05-2022 |
$0.03 | $0.025 | $0.03 | $0.03 | $0.025 | 225,201 | 03-31-2022 |
$0.03 | $0.025 | $0.03 | $0.03 | $0.025 | 200,330 | 03-30-2022 |
$0.03 | $0.025 | $0.03 | $0.03 | $0.025 | 67,800 | 03-29-2022 |
$0.03 | $0.03 | $0.03 | $0.03 | $0.025 | 198,289 | 03-28-2022 |
$0.03 | $0.025 | $0.03 | $0.03 | $0.025 | 40,485 | 03-23-2022 |
$0.025 | $0.025 | $0.025 | $0.025 | $0.025 | 158,900 | 03-17-2022 |
$0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 150,000 | 03-16-2022 |
News, Short Squeeze, Breakout and More Instantly...
Lobe Sciences Ltd. Company Name:
LOBE:CC Stock Symbol:
CNQC Market:
Company Exploring Alternative Value Creation Opportunities Convertible note for $500,000.00 USD, Short-term Debt Reduced and Balance Sheet Strengthened to Prepare the Company for Long Term Funding Strategy Annual General Meeting Set for 22 July 2024 Lobe Sciences Ltd. (O...
Accomplished Investor and Serial Entrepreneur Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced that Wesley Ramjeet has agreed to join its Board of Di...
Providing a Proven Track Record of Driving Growth and Innovation Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced that Frederick D. Sancilio Ph.D. ha...